Drugs delivered during their molecular target’s daily downtime often do more harm than good, which is why biologists have struggled to pinpoint the precise timing of these molecules’ delivery systems
Working with mouse models of colon and breast cancer, researchers demonstrated that when combined with chemotherapy, the nanoparticle reduced tumor growth substantially more than chemotherapy alone
A new tumor-modeling platform called a tumor-microenvironment-on-chip can be used to visualize and quantify how different types of cancer cells react differently to the chemotherapy drug doxorubicin